Epilepsiya i migren'


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Migraine and epilepsy are most common neurological diseases, manifested with paroxysmal disorders. The prevalence of epilepsy in people with migraine varies from 1 to 17% with a median of 5.9%, that is significantly higher than the average in the population (0.5%), and the prevalence of migraine in epileptic patients is 8-15%. Clinical manifestations of migrainous and epileptic attacks may be similar, making difficult differential diagnosis, for which the most important tool is history-taking. Electroencephalography (EEG) may be useful for patients with headache and signs of epilepsy, such as atypical aura or episodes of unconsciousness. Prolonged video-EEG monitoring is used as a differential diagnosis for migrainous and epileptic aura and objectification a comorbide migraine and epilepsy or migralepsy syndrome. In case of combination of migraine and epilepsy, drugs effective in both disorders (valproate and topiramate) should be preferred

Full Text

Restricted Access

About the authors

A. S Kotov

References

  1. American Academy of Neurology Quality Standards Subcommittee. Practice parameter: the electroencephalogram in the evaluation of headache (summary statement). Report of the Quality Standards Subcommittee. Neurology. 1995;45:1411-13.
  2. Amery WK, Waelkens J, Caers I. Dopaminergic mechanisms in premonitory phenomena. In: Amery WK, Wauquier A, eds. The Prelude to the Migraine Attack. London: Bailliere Tindall; 1986:64-77.
  3. Amery WK, Waelkens J, Van den Bergh V. Migraine warnings. Headache. 1986;26:60-6.
  4. Andermann E, Andermann FA. Migraine-epilepsy relationships: epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:281-91.
  5. Andermann F. Clinical features of migraine-epilepsy syndrome. In: Andermann F1 Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:3-30.
  6. Andermann F. Migraine and epilepsy: an overview. In: Andermann F, Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:405-21.
  7. Appenzeller O. Posttraumatic headaches. In: Dalessio DJ, Silberstein SD, eds. Wolff's Headache and Other Head Pain. 6th ed. New York: Oxford University Press; 1993:365-83.
  8. BeaumanoirA, Jekiel M. Electrographic observations during attacks of classical migraine. In: Andermann F1 Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:163-80.
  9. Blau JN. Migraine prodromes separated from the aura: complete migraine. BMJ. 1980;281:658-60.
  10. Creange A, Zeller J, Rostaing-Rigattieri S, et al. Neurological complications of neurofibromatosis type 1 in adulthood. Brain. 1999;122:373-81.
  11. Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465-69.
  12. Ehrenberg BL. Unusual clinical manifestations of migraine, and "the borderland of epilepsy" re-explored. Semin Neurol. 1991;11:118-27.
  13. Fenwick P Episodic dyscontrol. In: Engel J, Pedley T, eds. Epilepsy: Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1998:2767-2774.
  14. Gastaut H. A new type of epilepsy: benign partial epilepsy childhood with occipital spike-waves. Clin Electroencephalogr. 1982; 13:13-22.
  15. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology. 2003;60:935-40.
  16. Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature. Neurology. 1995;45:1263-67.
  17. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura. Neurology. 1994;44:647-51.
  18. Lipton RB, Ottman R, Ehrenberg BL, et al. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994; 44:28-32.
  19. Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994;44:4-5.
  20. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319-28.
  21. Lipton RB, Stewart WF, Celentano DD, et al. Undiagnosed migraine headaches: a comparison of symptom-based and reported physician diagnosis. Arch intern Med. 1992; 156:12 73-78.
  22. Lipton RB, Stewart WF1 Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study ii. Headache. 2001;41:646-57.
  23. Maria BL, Neufeld JA, Rosainz LC, et al. Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression. J Child Neurol. 1998;13:606-18.
  24. Marks DA, Ehrenberg BL. Migraine related seizures in adults with epilepsy, with EEG correlation. Neurology. 1993;43:2476-83.
  25. Mathew NT. Valproate in the treatment of persistent chronic daily headache. Headache. 1990;30:301.
  26. Multon S, Schoenen J. Pain control by vagus nerve stimulation: from animal to man..and back. Acta Neurol Belg. 2005;105:62-67.
  27. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44:2105-10.
  28. Panayiotopoulos CP. Difficulties in differentiating migraine and epilepsy based on clinical and EEG findings. in: Andermann F, Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworth; 1987:31-46.
  29. Panayiotopoulos CP. Benign childhood epilepsy with occipital paroxysms: a 15-year prospective study. Ann Neurol. 1989;26:51-6.
  30. Panayiotopoulos CP. Differentiating occipital epilepsies from migraine with aura, acephalgic migraine and basilar migraine. in: Panayiotopoulos CP1 ed. Benign Childhood Partial Seizures and Related Epileptic Syndromes. London: John Libbey & Company Ltd.; 1999:281-302.
  31. Pearce JMS. Migraine: a cerebral disorder. Lancet. 1984;11:86-9.
  32. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the international League Against Epilepsy. Epilepsia. 1989;30:389-99.
  33. Selby G, Lance JW. Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry. 1960;23:23-32.
  34. Sianard-Gainko J, Lenaerts M, Bastings E, et al. Sodium valproate in severe migraine and tensiontype headache: clinical efficacy and correlations with blood levels. Cephalalgia. 1993;13:252.
  35. Silberstein SD, Lipton RB. Epidemiology of migraine. Neuroepidemiology. 1993;12:179-94.
  36. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology. 1994; 44:6-16.
  37. Silberstein SD, Saper JR, Freitag F. Migraine: diagnosis and treatment. in: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's Headache and Other Head Pain. 7th ed. New York: Oxford University Press; 2001:121-237.
  38. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol. 1995;45:175-82.
  39. So NK, Andermann F. Differential diagnosis. in: Engel J, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Publishers; 1997:791.
  40. Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand. 1988;78:346-48.
  41. Ziegler DK, Hassanein RS. Specific headache phenomena: their frequency and coincidence. Headache. 1990;30:152-56.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies